Regen BioPharma Inc (RGBP)

[cvinvestor]

I believe one or more will be approved for clinical trials. Time and effort needed to get to approval as "drug" treatment for everyone is another issue I have not addressed. RGBP itself says their goal is to get products to and through phase 1, 2 process and then sell or spin them off. What will happen in that regard for HemaX, dCellVax and/or NR2F6 remains to be seen, but yes, I do believe HemaX from what we've been told, should get final FDA approval to move to 10 patient human clinical trials and that of itself will help put them on the map and radar of larger pharma companies.